Executive summary 50 years after a noble but flawed attempt to eradicate malaria in the mid-
20th century, the global malaria community is once again seriously considering eradication …

Plasmodium vivax is the most widespread human malaria, putting 2.5 billion people at risk of
infection. Its unique biological and epidemiological characteristics pose challenges to …

Background Malaria causes significant morbidity and mortality each year. In the past few
years, the global malaria cases have been declining and many endemic countries are …

Over the past 50 years, Plasmodium falciparum has developed resistance against all
antimalarial drugs used against it: chloroquine, sulphadoxine–pyrimethamine, quinine …

Malaria, caused by the protozoan parasites of the genus Plasmodium, is a major health
problem in many countries of the world. Five parasite species namely, Plasmodium …

Malaria in sub-Saharan Africa has historically been almost exclusively attributed to
Plasmodium falciparum (Pf). Current diagnostic and surveillance systems in much of sub …

With malaria elimination back on the international agenda, programs face the challenge of
targeting all Plasmodium infections, not only symptomatic cases. As asymptomatic …

Important strides have been made within the past decade toward malaria elimination in
many regions, and with this progress, the feasibility of eradication is once again under …

Background Ever since it was discovered that zoophilic vectors can transmit malaria,
zooprophylaxis has been used to prevent the disease. However, zoopotentiation has also …

The world has made tremendous progress in the fight against malaria in the past 15 years.
According to the World Malaria Report, malaria case incidence was reduced by 41 percent …